Skip to main content
You're viewing the free public version. Create a free account for full research and member tools. Join free
Research Abstract Animal Study

Protective effects of Boswellia and Curcuma extract on oxaliplatin-induced neuropathy.

Protective effects ofandextract on oxaliplatin-induced neuropathy via modulation of NF-κB signaling.

0:00 / 0:00
0:00 / 0:00

Sign in to access this feature

Create a free account or sign in to use AI summaries, listen to articles, download PDFs, and save to your library.

89 views
Share:

Abstract

Oxaliplatin is a third-generation anticancer agent with better efficacy, lower toxicity, and a broad spectrum of antineoplastic activity. Its use is frequently associated with chronic oxaliplatin-induced neuropathy (OIN), a cumulative phenomenon manifesting as loss of sensation, paresthesia, dysesthesia, and irresolvable fluctuations in proprioception that greatly affect the patients' quality of life. The inevitable nature and high incidence of OIN, along with the absence of efficacious preventive agents, necessitate the development of effective and reliable protective options for limiting OIN while maintaining anticancer activity. The pathogenesis of chronic OIN involves neuroinflammation and oxidative stress. This study aimed to explore the neuroprotective effects ofandvia modulation of nuclear factor-kappa B (NF-κB) signaling. Behavioral tests were conducted to assess cold allodynia, heat hyperalgesia, mechanical allodynia, mechanical hyperalgesia, and slowed nerve conduction velocity associated with chronic oxaliplatin administration. The modulation of NF-κB signaling and the subsequent activation of cytokines were evaluated through quantitative analysis of inflammatory cytokines in sciatic nerve homogenates. Additional assessments included oxidative stress parameters, serum neuronal biomarkers, and examination of sciatic nerve cross-sections. The findings indicate improvements in behavioral and biochemical parameters, as well as nerve histology, with the combined extract ofandat doses of 50 mg/kg and 75 mg/kg. Thus, this study presents evidence for the protective potential of the combined extract ofandin OIN through modulation of NF-κB signaling.

Affiliation

Sakshi Mahajan

External References

PubMed ID:
39512239

Comments

Sign in or create a free account to join the conversation.

Sign in to comment

Be the first to comment.

More Research Abstracts

View All Abstracts
Animal Study

Study on the Preparation of Frankincense volatile oil submicro emulsion and its effect on ulcerative colitis.

Jan 8, 2026 Mei Liu, Yujiao Wang, Mengmeng Wang, Le Zhang, Zihao Niu, Xuan Wang, Jie Wang, Ning Xia, Jinhui Wang, Xiaoxiao Ge, Chao Chen, Qin Chen, Shihao Zhang, Yundong Xie, Huanxian Shi, Chongbo Zhao, Junbo Zou, Dongyan Guo, Yajun Shi, Ming Yang, Zhennan She, Xiaofei Zhang, Jing Sun

Curr Drug Deliv

Trusted By Professionals and Teams:

The National Health Federation
Stand For Health Freedom
Global Healing Institute
Global Wellness Forum
MAHA Action
Myers Detox
Natural News
Mercola.com

Unlock Evidence-Based Health Research

Join 500,000+ members accessing 10,000+ natural health topics.

Subscribe to our informative Newsletter & Receive

Cancer Fighting Foods Ebook

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.